Skip to main content
. 2017 Sep 30;34(3):209–216. doi: 10.36141/svdld.v34i3.5727

Table 2.

Organ manifestation reported by race

Chinese (Han) US (all) Pc& Black White Pc
Lung * 475 (98.8) 393 (87.7) <0.001 187 (88.8) 204 (86.8) NS§
Neurologic 6 (1.2) 75 (14.4) <0.001 38 (15.7) 37 (13.4) NS
Non-thoracic lymph node 80 (16.6) 74 (14.2) NS 28 (11.6) 46 (16.6) NS
Renal 0 (0.0) 6 (1.1) NS 2 (0.8) 4 (1.4) NS
Cardiac 1 (0.2) 31 (6.0) <0.001 11 (5.2) 19 (8.1) NS
Skin 51 (10.6) 124 (27.7) <0.001 66 (31.3) 58 (24.7) NS
Eye 30 (6.2) 145 (32.4) <0.001 83 (39.3) 62 (26.4) 0.015
Liver 7 (1.5) 57 (10.9) <0.001 31 (12.8) 25 (9.0) NS
Bone marrow 1 (0.2) 11 (2.1) NS 3 (1.2) 8 (2.9) NS
Spleen 12 (2.5) 35 (6.7) 0.03 16 (6.6) 19 (6.9) NS
Bone/joint 10 (2.1) 20 (3.8) NS 5 (2.1) 15 (5.4) NS
Head/neck 4 (0.8) 22 (4.2) 0.03 13 (5.4) 9 (3.2) NS
Parotid/ Salivary 4 (0.8) 6 (1.1) NS 1 (0.4) 5 (1.8) NS
Muscle 3 (0.6) 0 (0.0) NS 0 (0.0) 0 (0.0) NS
Hypercalcemia/hypercalciuria 115 (23.9) 63 (14.1) <0.001 16 (7.6) 47 (20.0) <0.001

*According to WASOG criteria, biopsy confirmed or at least one clinical condition was “at least probable” as representing sarcoidosis.

†Pc: P values were corrected multiple testing of disease manifestations (fifteen tested) according to Bonferroni’s correction.

§NS: no significant difference.